Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.94 USD | -3.67% | +0.39% | +71.65% |
Apr. 19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
Mar. 28 | Truist Securities Initiates Coverage on Merus With Buy Rating, $69 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.65% | 2.86B | |
+3.51% | 106B | |
+7.02% | 23.47B | |
-15.15% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-9.76% | 16.78B | |
+5.91% | 14.41B | |
+34.32% | 12.86B | |
+313.33% | 8.78B |
- Stock Market
- Equities
- MRUS Stock
- News Merus N.V.
- Merus Regains Worldwide Rights to MCLA-145 After Incyte Opt-Out; Names Chief Commercial Officer